Mimedx (MDXG) Net Income towards Common Stockholders Growth (1y) (2012 - 2026)
Powered by 
Analysis
Mimedx (MDXG) Net Income towards Common Stockholders Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.70 Bn | 177.10 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 126.82 Bn | 121.60 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 117.93 Bn | 109.11 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 104.83 Bn | 101.36 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 64.79 Bn | 64.25 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.83 Bn | 45.58 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.14 Bn | 30.20 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | 12.92% |
| 10 | Mimedx | 673.21 Mn | 537.37 Mn | 44.38 Mn | -254.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -254.29% |
| Mar 31, 2026 | -254.63% |
| Dec 31, 2025 | 104.24% |
| Sep 30, 2025 | 112.59% |
| Jun 30, 2025 | -45.42% |
| Mar 31, 2025 | -22.49% |
| Dec 31, 2024 | -83.41% |
| Sep 30, 2024 | 11.44% |
| Jun 30, 2024 | 134.23% |
| Mar 31, 2024 | 349.89% |
| Dec 31, 2023 | 451.13% |
| Sep 30, 2023 | 170.02% |
| Jun 30, 2023 | 160.20% |
| Mar 31, 2023 | 69.97% |
| Dec 31, 2022 | 681.83% |
| Sep 30, 2022 | -158.01% |
| Jun 30, 2022 | -281.44% |
| Mar 31, 2022 | -22.59% |
| Dec 31, 2021 | 92.26% |
| Sep 30, 2021 | 92.47% |